Glaucoma is a mixed group of optic neuropathies that lead to irreversible visual field loss
and blindness if left untreated. It is estimated that 3.5% of the global population aged 40 to …

Purpose To describe the associations of physical and demographic factors with Goldmann-
correlated intraocular pressure (IOPg) and corneal-compensated intraocular pressure …

Abstract DARC (Detection of Apoptosing Retinal Cells) is a retinal imaging technology that
has been developed within the last 2 decades from basic laboratory science to Phase 2 …

Purpose: This study aimed to evaluate the prevalence of POAG in Europe. Methods: Two
authors independently conducted a systematic literature search on PubMed/MedLine, Web …

Purpose To assess the efficacy and safety of different regimens, including monotherapy and
double therapy, for primary open‐angle glaucoma (POAG) or ocular hypertension. Methods …

Background: Glaucoma is a leading cause of irreversible blindness worldwide. The
increasing interest in the involvement of the cortical visual pathway in glaucomatous patients …

Glaucoma a debilitating disease, is globally the second most common kind of permanent
blindness. Primary open-angle glaucoma (POAG) is its most prevalent form and is often …

The pathogenesis of glaucoma is incompletely understood, but the death of axons grouped
together at the optic disc implies that this anatomic area is primarily involved. The typical …

Elevation of intraocular pressure (IOP) due to trabecular meshwork (TM) damage is
associated with primary open-angle glaucoma (POAG). Myocilin mutations resulting in …

Hypothesis Glaucoma is effectively treated by prostaglandin analogs. Low corneal
bioavailability (< 5%) of daily-instilled prostaglandin drops complemented by frequent …